Discrete Choice Experiment to Understand Japanese Patients’ and Physicians’ Preferences for Preventive Treatments for Migraine

Abstract Introduction Self-injectable calcitonin gene-related peptide (CGRP) monoclonal antibody (mAb) auto-injectors and non-CGRP oral medications are currently available for migraine prevention in Japan. This study elicited the preferences for self-injectable CGRP mAbs and non-CGRP oral medication...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Jaein Seo, Tommi Tervonen, Kaname Ueda, Dian Zhang, Daisuke Danno, Antje Tockhorn-Heidenreich
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2023-02-01
Sarja:	Neurology and Therapy
Aiheet:	CGRP monoclonal antibody Discrete choice experiment Migraine prevention Patient and physician preferences
Linkit:	https://doi.org/10.1007/s40120-023-00453-0
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!